BioHarvest Sciences rilis presentasi korporasi soal platform kultur sel tanaman untuk produksi senyawa berbasis botani
PUBT · 1d ago
Share
Listen to the news
- Bioharvest Sciences Inc. mematok panduan pendapatan 2026 sebesar USD 37-40 juta; D2C USD 33-35 juta, CDMO USD 4-5 juta.
- Perusahaan menargetkan bisnis D2C bergerak menuju profitabilitas, dipacu penjualan VINIA ke kanal pelanggan baru.
- VINIA mencatat penjualan kumulatif melebihi USD 100 juta sejak masuk pasar AS pada 2021; sekitar 95.000 pengguna aktif D2C.
- Kesepakatan pasokan manufaktur 20 ton untuk botani langka parfum mewah diproyeksikan menghasilkan USD 20-30 juta pada 2027-2028.
- Platform CDMO menampilkan empat program lintas kosmetik/fragrance, nutraseutikal, farmasi, nutrisi; beberapa proyek melaju ke Tahap 2.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioharvest Sciences Inc. published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending